Stock Scorecard
Stock Summary for Collegium Pharmaceutical Inc (COLL) - $27.33 as of 12/8/2023 8:46:13 PM EST
Total Score
9 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for COLL
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for COLL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for COLL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for COLL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for COLL
Financial Details for COLL
Company Overview |
|
|---|---|
| Ticker | COLL |
| Company Name | Collegium Pharmaceutical Inc |
| Country | USA |
| Description | Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 9/30/2023 |
| Next Earnings Date | 2/21/2024 |
Stock Price History |
|
| Last Day Price | 27.33 |
| Last Day Price Updated | 12/8/2023 8:46:13 PM EST |
| Last Day Volume | 0 |
| Average Daily Volume | N/A |
| 52-Week High | 30.22 |
| 52-Week Low | 20.83 |
| Last Price to 52 Week Low | 31.20 % |
Valuation Measures |
|
| Trailing PE | 113.88 |
| Industry PE | 57.56 |
| Sector PE | 62.37 |
| 5-Year Average PE | 29.50 |
| Free Cash Flow Ratio | 2.54 |
| Industry Free Cash Flow Ratio | 10.37 |
| Sector Free Cash Flow Ratio | 31.15 |
| Current Ratio Most Recent Quarter | 1.16 |
| Total Cash Per Share | 10.75 |
| Book Value Per Share Most Recent Quarter | 5.41 |
| Price to Book Ratio | 4.98 |
| Industry Price to Book Ratio | 4.33 |
| Sector Price to Book Ratio | 19.59 |
| Price to Sales Ratio Twelve Trailing Months | 1.63 |
| Industry Price to Sales Ratio Twelve Trailing Months | 10.29 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.61 |
Share Statistics |
|
| Total Shares Outstanding | 32,610,900 |
| Market Capitalization | 891,255,897 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Dividend King? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00 % |
| 5-Year Dividend Payments Count | 0 |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 5,198.00 % |
| Annual Earnings Growth | -134.96 % |
| Reported EPS 12 Trailing Months | 0.24 |
| Reported EPS Past Year | 0.36 |
| Reported EPS Prior Year | 0.56 |
| Net Income Twelve Trailing Months | 9,016,000 |
| Net Income Past Year | -25,002,000 |
| Net Income Prior Year | 71,517,000 |
| Quarterly Revenue Growth YOY | 7.60 % |
| 5-Year Revenue Growth | -7.22 % |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 350,598,000 |
| Total Cash Past Year | 173,688,000 |
| Total Cash Prior Year | 186,426,000 |
| Net Cash Position Most Recent Quarter | -360,444,000 |
| Net Cash Position Past Year | -527,263,000 |
| Long Term Debt Past Year | 700,951,000 |
| Long Term Debt Prior Year | 249,985,000 |
| Total Debt Most Recent Quarter | 711,042,000 |
| Equity to Debt Ratio Past Year | 0.22 |
| Equity to Debt Ratio Most Recent Quarter | 0.20 |
| Total Stockholder Equity Past Year | 194,842,000 |
| Total Stockholder Equity Prior Year | 202,928,000 |
| Total Stockholder Equity Most Recent Quarter | 178,873,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.81 |
| MACD Signal | 0.80 |
| 20-Day Bollinger Lower Band | 20.49 |
| 20-Day Bollinger Middle Band | 23.56 |
| 20-Day Bollinger Upper Band | 26.63 |
| Beta | 0.93 |
| RSI | 68.77 |
| 50-Day SMA | 23.96 |
| 200-Day SMA | 20.89 |
System |
|
| Modified | 12/10/2023 10:22:12 AM EST |